76 Biggest Movers From Yesterday
Gainers
Expensify, Inc. (NASDAQ: EXFY) jumped 52.1% to settle at $41.06 on Wednesday after the company priced its IPO at $27 per share.
Why Did Mizuho Upgrade This Biotech Stock Focused On Age-Related Eye Diseases?
Mizuho upgraded Unity Biotechnology Inc (NASDAQ:UBX) to Buy from Neutral with a price target of $7, up from $5 after Unity announced…
55 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
RenovoRx, Inc. (NASDAQ: RNXT) shares jumped 128% to $12.41. The company, on Tuesday evening, made a presentation on intra-arterial chemotherapy as a potential innovative treatment for pancreatic cancer.
30 Stocks Moving in Wednesday’s Pre-Market Session
Gainers
RenovoRx, Inc. (NASDAQ: RNXT) rose 113% to $11.50 in pre-market trading. The company, on Tuesday evening, made a presentation on intra-arterial chemotherapy as a potential innovative treatment for pancreatic cancer.
Mizuho Upgrades Unity Biotechnology to Buy, Raises Price Target to $7
Mizuho upgrades Unity Biotechnology (NASDAQ:UBX) from Neutral to Buy and raises the price target from $5 to $7.
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 7)
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer’s Sleep Disorder Drug Filing Accepted For Review, Voyager’s Licensing Options Deal
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 5)